Although this study has to some extent revealed the possible molecular mechanism of CFDTW in improving phlegm dampness type PCOS by regulating the PKP3/MAPK/ERCC1 signal axis, there are still the following limitations. This evidence concerns the gene PKP3 and polycystic ovary syndrome.